Global Bioenergies SA
PAR:ALGBE
Global Bioenergies SA
PAR:ALGBE
Price:
0.0185
EUR
Market Closed
Market Cap:
€336.1k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Global Bioenergies SA
PAR:ALGBE
|
FR |
|
T
|
Titan Intech Ltd
BSE:521005
|
IN |
|
H
|
HHRG Bhd
KLSE:HHRG
|
MY |
|
S
|
Sprott Inc
NYSE:SII
|
CA |
Balance Sheet
Balance Sheet Decomposition
Global Bioenergies SA
Global Bioenergies SA
Balance Sheet Decomposition is not available for
Global Bioenergies SA
Global Bioenergies SA
Balance Sheet
Global Bioenergies SA
Global Bioenergies SA
Currency: EUR
| Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
6
|
24
|
15
|
10
|
8
|
14
|
11
|
17
|
15
|
21
|
9
|
12
|
5
|
|
| Cash |
0
|
23
|
15
|
9
|
7
|
13
|
10
|
17
|
14
|
21
|
9
|
12
|
5
|
|
| Cash Equivalents |
6
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
2
|
2
|
4
|
3
|
4
|
4
|
4
|
3
|
5
|
4
|
4
|
2
|
3
|
|
| Accounts Receivables |
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
1
|
2
|
3
|
3
|
4
|
4
|
4
|
3
|
5
|
4
|
4
|
2
|
3
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
3
|
1
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
9
|
26
|
20
|
15
|
13
|
18
|
15
|
21
|
22
|
27
|
15
|
15
|
9
|
|
| PP&E Net |
0
|
1
|
2
|
7
|
12
|
11
|
8
|
5
|
2
|
3
|
4
|
3
|
0
|
|
| PP&E Gross |
0
|
1
|
2
|
7
|
12
|
11
|
8
|
5
|
2
|
3
|
4
|
3
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
6
|
10
|
13
|
16
|
8
|
11
|
12
|
14
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Long-Term Investments |
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Assets |
9
N/A
|
26
+184%
|
24
-9%
|
22
-8%
|
26
+15%
|
31
+21%
|
25
-18%
|
28
+10%
|
26
-8%
|
32
+23%
|
22
-32%
|
18
-15%
|
10
-47%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
1
|
1
|
2
|
3
|
4
|
5
|
3
|
3
|
3
|
4
|
6
|
2
|
1
|
|
| Accrued Liabilities |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
2
|
1
|
5
|
7
|
9
|
13
|
13
|
12
|
4
|
3
|
1
|
1
|
|
| Total Current Liabilities |
3
|
3
|
4
|
9
|
13
|
16
|
18
|
17
|
16
|
8
|
9
|
4
|
3
|
|
| Long-Term Debt |
0
|
1
|
2
|
5
|
3
|
2
|
2
|
1
|
6
|
5
|
5
|
4
|
5
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
3
N/A
|
3
+19%
|
6
+80%
|
14
+133%
|
16
+13%
|
17
+5%
|
19
+12%
|
18
-5%
|
22
+19%
|
13
-39%
|
14
+6%
|
8
-44%
|
8
+1%
|
|
| Equity | ||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
7
|
12
|
18
|
30
|
41
|
55
|
69
|
81
|
92
|
16
|
15
|
11
|
7
|
|
| Additional Paid In Capital |
13
|
35
|
36
|
38
|
49
|
68
|
74
|
90
|
96
|
29
|
16
|
11
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
5
|
6
|
10
|
8
|
|
| Total Equity |
6
N/A
|
23
+257%
|
18
-22%
|
8
-56%
|
9
+18%
|
14
+48%
|
6
-54%
|
10
+55%
|
4
-57%
|
19
+352%
|
8
-59%
|
10
+36%
|
2
-84%
|
|
| Total Liabilities & Equity |
9
N/A
|
26
+184%
|
24
-9%
|
22
-8%
|
26
+15%
|
31
+21%
|
25
-18%
|
28
+10%
|
26
-8%
|
32
+23%
|
22
-32%
|
18
-15%
|
10
-47%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
2
|
3
|
3
|
3
|
3
|
5
|
5
|
9
|
10
|
15
|
15
|
18
|
18
|
|
Switch to:
Switch to:
See Also
Discover More
